Hemosiderosis - 27 Studies Found
Withdrawn |
: Treatment of Iron Overload Requiring Chelation Therapy :
|
Enrolling by invitation |
: A Case Control Study to Evaluate the Cognitive and Brain Function of β-thalassemia Patients. :
: 2013-08-07 |
Enrolling by invitation |
: PHOX2B Mutation-Confirmed Congenital Central Hypoventilation Syndrome in A Chinese Family: Presentations From Newborn to Adulthood : Central Alveolar Hypoventilation Syndrome : 2008-04-01 : Device: CPAP CPAP treatment for patients with congenital central hypoventilation syndrome |
Completed |
: Evaluation of the Safety, Tolerability, Pharmacokinetics (PK) and Effects on Liver Iron Concentration of ICL670 Relative to Deferoxamine(DFO). : Sickle Cell Disease : 2010-03-15 : Drug: ICL670 Daily doses of ICL670 were taken orally 30 minutes before breakfast. The doses range from 5 |
Completed |
: A Protocol to Allow Treatment With ICL670 for Patients With or at Risk of Life-threatening Complications of Transfusional Iron Overload Who Are Unable to Tolerate Other Iron Chelators Because of Documented Severe Toxicity : Transfusional Iron Overload : 2010-01-05 : Drug: ICL670 |
Not yet recruiting |
: Efficacy of Bone Marrow Mesenchymal Stem Cell in Pulmonary Hemosiderosis : Idiopathic Pulmonary Hemosiderosis : 2016-12-03 : Biological: Bone marrow mesenchymal stem cells in treatment of Idiopathic pulmonary hemosiderosis |
Not yet recruiting |
: PHOX2B Mutation-Confirmed Congenital Central Hypoventilation Syndrome in A Chinese Family: Presentations From Newborn to Adulthood : Central Alveolar Hypoventilation Syndrome : 2008-04-01 : Device: CPAP CPAP treatment for patients with congenital central hypoventilation syndrome |